Literature DB >> 27020297

Steady increase of lymphogranuloma venereum cases, Czech Republic, 2010 to 2015.

Filip Rob1, Kateřina Jůzlová, Helena Krutáková, Hana Zákoucká, Daniela Vaňousová, Zuzana Kružicová, Ladislav Machala, Dan Veselý, David Jilich, Jana Hercogová.   

Abstract

Since the notification of the first case of lymphogranuloma venereum (LGV) in the Czech Republic in 2010, the numbers of LGV cases have steadily increased in the country. In 2015, 40 LGV cases were diagnosed, bringing the total for 2010-2015, to 88 cases. The profile of the most affected group, HIV-positive men who have sex with men with a previous sexually transmitted infection, matches that of those described in LGV outbreaks in western Europe.

Entities:  

Keywords:  Chlamydia; Czech Republic; clinic; lymphogranuloma venereum - LGV; men who have sex with men - MSM; outbreaks; sexually transmitted infections

Mesh:

Year:  2016        PMID: 27020297     DOI: 10.2807/1560-7917.ES.2016.21.11.30165

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  3 in total

1.  The first case of lymphogranuloma venereum in a woman in East-Central Europe and its multiple co-infections.

Authors:  Katerina Juzlova; Filip Rob; Hana Zakoucka; Andrea Kubatova; Zuzana Secnikova; Martina Krasova; Petr Bohac; Jana Hercogova
Journal:  Folia Microbiol (Praha)       Date:  2017-07-24       Impact factor: 2.099

2.  Emergence of the lymphogranuloma venereum L2c genovariant, Hungary, 2012 to 2016.

Authors:  Fruzsina Petrovay; Eszter Balla; Tímea Erdősi
Journal:  Euro Surveill       Date:  2017-02-02

3.  Substantial underdiagnosis of lymphogranuloma venereum in men who have sex with men in Europe: preliminary findings from a multicentre surveillance pilot.

Authors:  Michelle Jayne Cole; Nigel Field; Rachel Pitt; Andrew J Amato-Gauci; Josip Begovac; Patrick D French; Darja Keše; Irena Klavs; Snjezana Zidovec Lepej; Katharina Pöcher; Angelika Stary; Horst Schalk; Gianfranco Spiteri; Gwenda Hughes
Journal:  Sex Transm Infect       Date:  2019-06-23       Impact factor: 3.519

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.